Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
VIAVI Solutions Inc. submitted a Form 144 notice related to proposed sales of Common stock via Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists restricted shares and performance-share awards with grant dates 08/28/2018, 05/28/2020, and 09/25/2020, and reports multiple recent dispositions including 20,238 and 104,552 shares on 05/05/2026.
Luke Scrivanich reported a Rule 144 sale of 13,901 shares of Common Stock on 02/13/2026 for proceeds of $369,628.98. The filing lists several classes of common stock awards and ESPP allocations by grant date, including Performance Shares and Employee Stock Purchase Plan entries with specified grant counts and dates.
Viavi Solutions senior vice president Luke M. Scrivanich reported selling 10,693 shares of Common Stock in open-market transactions at $53 per share. These insider sales were disclosed on a Form 4 filing for Viavi Solutions (ticker VIAV).
VIAVI SOLUTIONS INC. President & CEO Oleg Khaykin reported open-market sales of company common stock. He sold 20,238 indirectly owned shares held by his spouse at a weighted average price of about $54.77 per share, reducing that indirect position to zero. He also sold 104,552 directly owned shares at a weighted average price of about $54.61 per share, and held 1,482,702 shares directly after these transactions.
VIAVI SOLUTIONS INC. executive vice president and chief marketing and strategy officer Paul McNab executed an open-market sale of 2,727 shares of Common Stock at $54.96 per share. After this transaction, he directly holds 15,471 shares of VIAVI common stock.
VIAVI SOLUTIONS INC. director Doug Gilstrap reported an open-market sale of company stock. On May 5, 2026, he sold 10,000 shares of Common Stock at $55.00 per share. After this transaction, he directly holds 55,766 shares of Viavi common stock.
Viavi Solutions (VIAV) submitted Form 144 reporting proposed insider sales totaling 206,583 shares. The notice lists planned dispositions by Oleg Khaykin and related irrevocable trusts on dates between 02/06/2026 and 02/10/2026, with aggregate proceeds shown as $5,503,089.71.
The securities are Common stock tied to Restricted Stock records; the filing is a notice of proposed sales under Form 144 rather than an executed market trade.
VIAV notice reports an affiliate sale filing under Form 144 for Common Stock consisting of 2,727 shares tied to performance shares, with the filing dated 05/05/2026. The filing also records prior dispositions of 3,551 shares on 03/02/2026 for $116,792.39. The broker/dealer listed is Morgan Stanley Smith Barney LLC and the securities trade on NASDAQ.
VIAV reported proposed sales of Common Stock on a Form 144 by affiliated trusts and an individual. The filing lists multiple proposed or completed transactions in February 2026, including sales of 20,000, 42,767, 73,250, 29,887 and 40,679 shares with dollar amounts shown for each trade.
The seller names include HELEN KHAYKIN IRREVOCABLE TRUST, OLEG KHAYKIN IRREVOCABLE TRUST, and OLEG KHAYKIN, with trade dates in 02/06/2026, 02/09/2026 and 02/10/2026.